Dementia, Alzheimers
When Memory Begins to Change, You Deserve to Know What Researchers Are Discovering.
If you or someone you love is facing Alzheimer’s disease or dementia, you may have heard that the focus is primarily on managing symptoms and slowing decline. But what if researchers are investigating ways to influence some of the biological processes behind that decline?
Regenerative medicine research in Alzheimer’s disease is moving into some fascinating territory—and increasingly, human studies are beginning to provide something to look at beyond laboratory theories.
Here are just a few of the findings you’ll discover in the research we’ll share:
A 2025 randomized, placebo-controlled human trial of an allogeneic mesenchymal cell therapy reported improvements in certain cognitive and daily-function measures at 39 weeks.
Even more intriguing, researchers found that treatment was associated with 48% slower whole-brain volume loss and 62% slower left hippocampal volume loss compared with placebo, along with evidence of reduced neuroinflammation. Larger trials are now warranted.
Another early human clinical trial investigated extracellular vesicles (exosomes) released by regenerative cells rather than the cells themselves. After 12 weeks of treatment, the medium-dose group showed improvements in two cognitive measures, and the ADAS-Cog improvement continued through week 36. Researchers are now studying whether these tiny biological “messengers” could influence the brain without transplanting the cells themselves.
And the research goes even further.
Scientists have found evidence that regenerative cells may influence microglia—the immune cells of the brain, which are increasingly recognized as important in Alzheimer’s disease. In an experimental Alzheimer’s model, researchers were able to preserve memory and cognition while reducing neuroinflammation and amyloid accumulation.
Other studies are investigating whether regenerative cells and their extracellular vesicles can influence oxidative stress, neuronal survival, inflammation, blood-brain-barrier function, and the biological signals that allow brain cells to communicate with one another.This is not proof that regenerative medicine can reverse Alzheimer’s disease. Much of the research remains early, and different cell sources, products and treatment approaches are being studied.
But there is enough emerging research—and now enough early human data—that we believe it is worth knowing what researchers are actually discovering.
Request the Complimentary Alzheimer’s & Dementia Research Collection
We’ll send you a carefully selected collection of links to the introductory research, along with short explanations of what each study investigated, what the researchers found, and links to the original publications.
You’ll see the encouraging findings.
You’ll also see the limitations and unanswered questions.
No sales pitch. No obligation. Just the research—so you can read it for yourself, ask better questions, and explore further.
When something as important as memory and cognitive function is at stake, shouldn't you know what researchers are investigating before deciding what is—or isn't—possible?
→ Request the Cognitive Complimentary Research Collection